Kayne Anderson Rudnick Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $681 | Hold |
14
| – | – | ﹤0.01% | 965 |
|
|
2025
Q1 | $476 | Hold |
14
| – | – | ﹤0.01% | 909 |
|
|
2024
Q4 | $551 | Hold |
14
| – | – | ﹤0.01% | 931 |
|
|
2024
Q3 | $658 | Hold |
14
| – | – | ﹤0.01% | 918 |
|
|
2024
Q2 | $756 | Hold |
14
| – | – | ﹤0.01% | 882 |
|
|
2024
Q1 | $954 | Buy |
+14
| New | +$954 | ﹤0.01% | 848 |
|
|
2023
Q4 | – | Sell |
-14
| Closed | -$635 | – | 970 |
|
|
2023
Q3 | $635 | Hold |
14
| – | – | ﹤0.01% | 775 |
|
|
2023
Q2 | $786 | Hold |
14
| – | – | ﹤0.01% | 768 |
|
|
2023
Q1 | $633 | Buy |
+14
| New | +$633 | ﹤0.01% | 669 |
|